SHL Telemedicine Ltd. Reports 2023 Annual Results
Ticker: SHMLF · Form: 6-K · Filed: Apr 17, 2024 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | Apr 17, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-results, filing, financial-report
TL;DR
SHL Telemedicine dropped its 2023 annual report and results on 4/17 - check it out.
AI Summary
On April 17, 2024, SHL Telemedicine Ltd. announced its 2023 annual results via a press release and investor presentation. These documents, filed with the SEC as exhibits to a Form 6-K, also include the company's Annual Report to shareholders for the year ended December 31, 2023, which was filed with the SIX Swiss Exchange.
Why It Matters
This filing provides investors with the company's official financial performance and strategic updates for the 2023 fiscal year, allowing for informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of annual results and does not introduce new risks.
Key Players & Entities
- SHL Telemedicine Ltd. (company) — Registrant
- April 17, 2024 (date) — Date of announcement and filing
- 2023 (date) — Fiscal year for reported results
- December 31, 2023 (date) — End of fiscal year
FAQ
What specific financial results are detailed in the press release and investor presentation?
The filing states that the press release and investor presentation contain the Company's 2023 annual results, but the specific financial figures are not detailed within the 6-K itself, rather they are incorporated by reference from the attached exhibits.
Where can investors find the detailed 2023 annual results?
Investors can find the detailed 2023 annual results in the press release (Exhibit 99.1) and the investor presentation (Exhibit 99.2) attached to the Form 6-K filing.
What is the significance of filing with the SIX Swiss Exchange?
The company filed its Annual Report to shareholders for the year ended December 31, 2023, with the SIX Swiss Exchange, indicating compliance with listing requirements in Switzerland.
Is this filing a new annual report or a supplement to an existing one?
This filing is a Form 6-K, which is a report of foreign private issuers and is used to furnish information to the SEC, in this case, announcing the release of their 2023 annual results and related documents.
What is the company's principal executive office address?
The company's principal executive offices are located at 90 Yigal Alon Street, Tel Aviv 67891, Israel.
Filing Stats: 344 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-04-17 06:37:54
Filing Documents
- zk2431296.htm (6-K) — 12KB
- exhibit_99-1.htm (EX-99.1) — 80KB
- exhibit_99-2.htm (EX-99.2) — 47KB
- exhibit_99-3.pdf (EX-99.3) — 821KB
- exhibit_99-2slide1.jpg (GRAPHIC) — 92KB
- exhibit_99-2slide2.jpg (GRAPHIC) — 287KB
- exhibit_99-2slide3.jpg (GRAPHIC) — 131KB
- exhibit_99-2slide4.jpg (GRAPHIC) — 137KB
- exhibit_99-2slide5.jpg (GRAPHIC) — 144KB
- exhibit_99-2slide6.jpg (GRAPHIC) — 154KB
- exhibit_99-2slide7.jpg (GRAPHIC) — 95KB
- exhibit_99-2slide8.jpg (GRAPHIC) — 169KB
- exhibit_99-2slide9.jpg (GRAPHIC) — 118KB
- exhibit_99-2slide10.jpg (GRAPHIC) — 144KB
- exhibit_99-2slide11.jpg (GRAPHIC) — 86KB
- exhibit_99-2slide12.jpg (GRAPHIC) — 151KB
- exhibit_99-2slide13.jpg (GRAPHIC) — 151KB
- exhibit_99-2slide14.jpg (GRAPHIC) — 86KB
- exhibit_99-2slide15.jpg (GRAPHIC) — 111KB
- exhibit_99-2slide16.jpg (GRAPHIC) — 179KB
- exhibit_99-2slide17.jpg (GRAPHIC) — 128KB
- exhibit_99-2slide18.jpg (GRAPHIC) — 89KB
- exhibit_99-2slide19.jpg (GRAPHIC) — 95KB
- exhibit_99-2slide20.jpg (GRAPHIC) — 111KB
- exhibit_99-2slide21.jpg (GRAPHIC) — 93KB
- exhibit_99-2slide22.jpg (GRAPHIC) — 182KB
- exhibit_99-2slide23.jpg (GRAPHIC) — 219KB
- image0.jpg (GRAPHIC) — 142KB
- image1.jpg (GRAPHIC) — 110KB
- 0001178913-24-001343.txt ( ) — 5962KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-41641 SHL TELEMEDICINE LTD. (Translation of registrant's name into English) 90 Yigal Alon Street Tel Aviv 67891, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXPLANATORY NOTE On April 17, 2024, SHL Telemedicine Ltd. (the "Company") issued a press release and an investor presentation with respect to its 2023 annual results, copies of which are attached hereto as Exhibits 99.1 and 99.2, respectively, and are incorporated by reference herein. In addition, on the same day the Company filed with the SIX Swiss Exchange its Annual Report to shareholders for the year ended December 31, 2023 (the "Report"), which contains audited consolidated financial statements as of and for the year ended December 31, 2023. A copy of the Report is attached hereto as Exhibit 99.3 and is incorporated by reference herein. The press release, investor presentation and Report contain forward-looking statements and include cautionary statements identifying important factors that could cause actual results to differ materially from those in the forward-looking statements. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546) . Exhibit Description 99.1 Press release, dated April 17, 2024, with respect to 2023 annual results. 99.2 Investor Presentation issued on April 17, 2024, with respect to 2023 annual results. 99.3 Annual Report to shareholders for the year ended December 31, 2023, filed with the SIX Swiss Exchange. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL Telemedicine Ltd. By: /s/ Amir Hai Amir Hai Chief Financial Officer April 17, 2024